Cargando…

Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov

BACKGROUND: ClinicalTrials.gov is valuable for aggregate-level analysis of trials. The recently published final rule aims to improve reporting of trial results. We aimed to assess variability in ClinicalTirals.gov records reporting participants’ baseline measures. METHODS AND FINDINGS: The September...

Descripción completa

Detalles Bibliográficos
Autores principales: Cahan, Amos, Anand, Vibha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673198/
https://www.ncbi.nlm.nih.gov/pubmed/29107973
http://dx.doi.org/10.1371/journal.pone.0185886
_version_ 1783276560960192512
author Cahan, Amos
Anand, Vibha
author_facet Cahan, Amos
Anand, Vibha
author_sort Cahan, Amos
collection PubMed
description BACKGROUND: ClinicalTrials.gov is valuable for aggregate-level analysis of trials. The recently published final rule aims to improve reporting of trial results. We aimed to assess variability in ClinicalTirals.gov records reporting participants’ baseline measures. METHODS AND FINDINGS: The September 2015 edition of the database for Aggregate Analysis of ClinicalTrials.gov (AACT), was used in this study. To date, AACT contains 186,941 trials of which 16,660 trials reporting baseline (participant) measures were analyzed. We also analyzed a subset of 13,818 Highly Likely Applicable Clinical Trials (HLACT), for which reporting of results is likely mandatory and compared a random sample of 30 trial records to their journal articles. We report counts for each mandatory baseline measure and variability reporting in their formats. The AACT dataset contains 8,161 baseline measures with 1206 unique measurement units. However, of these 6,940 (85%) variables appear only once in the dataset. Age and Gender are reported using many different formats (178 and 49 respectively). “Age” as the variable name is reported in 60 different formats. HLACT subset reports measures using 3,931 variables. The most frequent Age format (i.e. mean (years) ± sd) is found in only 45% of trials. Overall only 4 baseline measures (Region of Enrollment, Age, Number of Participants, and Gender) are reported by > 10% of trials. Discrepancies are found in both the types and formats of ClinicalTrials.gov records and their corresponding journal articles. On average, journal articles include twice the number of baseline measures (13.6±7.1 (sd) vs. 6.6±7.6) when compared to the ClinicalTrials.gov records that report any results. CONCLUSIONS: We found marked variability in baseline measures reporting. This is not addressed by the final rule. To support secondary use of ClinicalTrials.gov, a uniform format for baseline measures reporting is warranted.
format Online
Article
Text
id pubmed-5673198
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56731982017-11-18 Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov Cahan, Amos Anand, Vibha PLoS One Research Article BACKGROUND: ClinicalTrials.gov is valuable for aggregate-level analysis of trials. The recently published final rule aims to improve reporting of trial results. We aimed to assess variability in ClinicalTirals.gov records reporting participants’ baseline measures. METHODS AND FINDINGS: The September 2015 edition of the database for Aggregate Analysis of ClinicalTrials.gov (AACT), was used in this study. To date, AACT contains 186,941 trials of which 16,660 trials reporting baseline (participant) measures were analyzed. We also analyzed a subset of 13,818 Highly Likely Applicable Clinical Trials (HLACT), for which reporting of results is likely mandatory and compared a random sample of 30 trial records to their journal articles. We report counts for each mandatory baseline measure and variability reporting in their formats. The AACT dataset contains 8,161 baseline measures with 1206 unique measurement units. However, of these 6,940 (85%) variables appear only once in the dataset. Age and Gender are reported using many different formats (178 and 49 respectively). “Age” as the variable name is reported in 60 different formats. HLACT subset reports measures using 3,931 variables. The most frequent Age format (i.e. mean (years) ± sd) is found in only 45% of trials. Overall only 4 baseline measures (Region of Enrollment, Age, Number of Participants, and Gender) are reported by > 10% of trials. Discrepancies are found in both the types and formats of ClinicalTrials.gov records and their corresponding journal articles. On average, journal articles include twice the number of baseline measures (13.6±7.1 (sd) vs. 6.6±7.6) when compared to the ClinicalTrials.gov records that report any results. CONCLUSIONS: We found marked variability in baseline measures reporting. This is not addressed by the final rule. To support secondary use of ClinicalTrials.gov, a uniform format for baseline measures reporting is warranted. Public Library of Science 2017-11-06 /pmc/articles/PMC5673198/ /pubmed/29107973 http://dx.doi.org/10.1371/journal.pone.0185886 Text en © 2017 Cahan, Anand http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Cahan, Amos
Anand, Vibha
Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov
title Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov
title_full Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov
title_fullStr Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov
title_full_unstemmed Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov
title_short Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov
title_sort second thoughts on the final rule: an analysis of baseline participant characteristics reports on clinicaltrials.gov
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673198/
https://www.ncbi.nlm.nih.gov/pubmed/29107973
http://dx.doi.org/10.1371/journal.pone.0185886
work_keys_str_mv AT cahanamos secondthoughtsonthefinalruleananalysisofbaselineparticipantcharacteristicsreportsonclinicaltrialsgov
AT anandvibha secondthoughtsonthefinalruleananalysisofbaselineparticipantcharacteristicsreportsonclinicaltrialsgov